Herbert Smith Freehills (HSF) has appointed three new senior associates. They are Pilar Carrasco, Carmen Hermosín Peña and Marta Escartin Goizueta. Carrasco joins the competition department, while Hermosín Peña will join
Tags :sx1
Linkia Legal, based in Madrid, has been created to promote the arrival of French businesses in Spain by its founding partner and director, Sergio Román Alonso, and its managing partner, Carmen López Lizá
Uría Menéndez has advised ING Bank on the establishment of a bancassurance alliance with DKV Seguros for the joint development and marketing of health insurance products through the ING network in Spain. The
EY, Linklaters and Herbert Smith Freehills have advised on the sale of 49% of Bruc’s 1,066 megawatts portfolio to Interogo Holding. EY has advised Bruc, Linklaters has advised OPTrust, Universities Superannuation Scheme (USS) and the renewable
RSGM, a boutique specialising in insolvency law, has integrated the firm Corpolex to continue driving its growth strategy that will allow it to expand its portfolio of commercial law advisory services. Founded in 2018 by Pedro
Montero Aramburu Abogados has advised Ingeniatrics Tecnologías on the divestment process of different investment partners of the company. The advisory team of the firm has been coordinated by the Director of the commercial department
Gómez-Acebo & Pombo has advised Prestige and Limousine, one of the companies of the Cabify Group specialized in transportation, in Prejudicial Case C-50/21. The GA_P team has been led by Borja Carvajal, Pedro
Gómez-Acebo & Pombo has advised Enagás on its incorporation to the Hanseatic Energy Hub (HEH) project through the purchase of a 10% stake in the capital in substitution of Fluxys. Enagás’ investment is
Clifford Chance has advised the global coordinators, arrangers, bookrunners and lenders on the senior secured financing for an amount of 1.7 billion euros granted to the developer and manufacturer of metal automotive components Gestamp Automoción.
Clifford Chance has advised Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders on the sale of Spanish pharmaceutical company Inke to private equity firm Keensight Capital,
